Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aslan Pharmaceuticals
Special Reports
The 2024 Biotech Graveyard
Beware: ghosts of biotech’s past.
Gabrielle Masson
Oct 31, 2024 5:00am
Aslan’s dream of challenging Dupixent dies as biotech winds down
Jul 17, 2024 8:36am
20 years in, Singapore still searches for its biotech success story
Aug 6, 2023 8:00pm
Aslan hopes to take on Dupixent in AD with fewer side effects
Jul 6, 2023 11:20am
Aslan sells Japanese rights to would-be Dupixent rival for $12M
Jun 22, 2023 10:00am
Camp4 taps former Translate CMO for same role—Chutes & Ladders
Mar 18, 2022 9:30am
